We also found that the availability of TSPO binding sites in the hippocampus of patients with MDD had a significant negative correlation with serum adiponectin levels; the correlation analysis indicated that adiponectin accounted for about 10% of the variance of BPND in the population, as compared to a total variance of about 50%. This evidence concerns the gene ADIPOQ and major depressive disorder.